City University of New York (CUNY)

CUNY Academic Works
Publications and Research

Hunter College

2014

Functionally distinct PI 3-kinase pathways regulate myelination in
the peripheral nervous system
Bradley A. Heller
New York University

Monica Ghidinelli
University of Buffalo

Jakob Voelkl
University of Tübingen

Steven Einheber
CUNY Hunter College

Ryan Smith
New York University

See next page for additional authors

How does access to this work benefit you? Let us know!
More information about this work at: https://academicworks.cuny.edu/hc_pubs/153
Discover additional works at: https://academicworks.cuny.edu
This work is made publicly available by the City University of New York (CUNY).
Contact: AcademicWorks@cuny.edu

Authors
Bradley A. Heller, Monica Ghidinelli, Jakob Voelkl, Steven Einheber, Ryan Smith, Ethan Grund, Grant
Morahan, David Chandler, Luba Kalaydjieva, Filippo Giancotti, Rosalind H. King, Aniko Naray Fejes-Toth,
Gerard Fejes-Toth, Maria Laura Feltri, Florian Lang, and James L. Salzer

This article is available at CUNY Academic Works: https://academicworks.cuny.edu/hc_pubs/153

JCB: Article

Functionally distinct PI 3-kinase pathways regulate
myelination in the peripheral nervous system
Bradley A. Heller,1 Monica Ghidinelli,3 Jakob Voelkl,4 Steven Einheber,5 Ryan Smith,1 Ethan Grund,1 Grant Morahan,6
David Chandler,6 Luba Kalaydjieva,6 Filippo Giancotti,7 Rosalind H. King,8 Aniko Naray Fejes-Toth,9
Gerard Fejes-Toth,9 Maria Laura Feltri,3 Florian Lang,4 and James L. Salzer1,2
1

Neuroscience Institute and 2Departments of Neuroscience and Physiology and Neurology, NYU Langone Medical Center, New York, NY 10016
University of Buffalo School of Medicine, Hunter James Kelly Research Institute, Buffalo, NY 14214
4
Department of Physiology, University of Tübingen, 72076 Tübingen, Germany
5
Department of Medical Laboratory Sciences, Hunter College, City University of New York, New York, NY 10010
6
Western Australian Institute for Medical Research/Centre for Medical Research, The University of Western Australia, Perth 6009, Australia
7
Department of Cell Biology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065
8
UCL Institute of Neurology, University College London, London NW3 2PF, England, UK
9
Department of Physiology and Neurobiology, Geisel School of Medicine, Dartmouth College, Lebanon, NH 03756

THE JOURNAL OF CELL BIOLOGY

3

T

he PI 3-kinase (PI 3-K) signaling pathway is essential for Schwann cell myelination. Here we have
characterized PI 3-K effectors activated during
myelination by probing myelinating cultures and developing nerves with an antibody that recognizes phosphorylated substrates for this pathway. We identified a
discrete number of phospho-proteins including the S6
ribosomal protein (S6rp), which is down-regulated at the
onset of myelination, and N-myc downstream-regulated
gene-1 (NDRG1), which is up-regulated strikingly with
myelination. We show that type III Neuregulin1 on the
axon is the primary activator of S6rp, an effector of

mTORC1. In contrast, laminin-2 in the extracellular
matrix (ECM), signaling through the 64 integrin and Sgk1
(serum and glucocorticoid-induced kinase 1), drives phosphorylation of NDRG1 in the Cajal bands of the abaxonal compartment. Unexpectedly, mice deficient in 64
integrin signaling or Sgk1 exhibit hypermyelination during development. These results identify functionally and
spatially distinct PI 3-K pathways: an early, pro-myelinating
pathway driven by axonal Neuregulin1 and a lateracting, laminin–integrin-dependent pathway that negatively regulates myelination.

Introduction
The myelin sheath is critical for the rapid and efficient conduction of nerve impulses in the vertebrate nervous system (Richie,
1984). Myelin forms in stages. In the developing peripheral nervous system (PNS), Schwann cells first segregate off large diameter axons into a 1:1 relationship, a process termed radial
sorting (Feltri and Wrabetz, 2005; Sherman and Brophy, 2005).
Subsequently, Schwann cells circumferentially extend a membrane process around the axon to form the myelin sheath (Bunge
et al., 1989). In contrast, small-caliber axons remain ensheathed
within separate pockets of a nonmyelinating Schwann cell,
forming a Remak bundle (Griffin and Thompson, 2008).
Correspondence to James L. Salzer: james.salzer@nyumc.org
Abbreviations used in this paper: -DG, -dystroglycan; MBP, myelin basic
protein; mTor, mammalian target of rapamycin; NDRG1, N-myc downstream–
regulated gene-1; P0, myelin protein zero; PI 3-K, phosphatidylinositol 3-kinase;
PNS, peripheral nervous system; p-Sub; phospho-substrate; PTEN, phosphatase
and tensin homologue; S6rp, S6 ribosomal protein; Sgk, serum and glucocorticoidinduced kinase; SLI, Schmidt Lanterman incisures.
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The signals that direct Schwann cells to initiate myelination and regulate the thickness of the myelin sheath are incompletely understood (Pereira et al., 2012; Salzer, 2012). Two
broad sources of extrinsic signals have been implicated in these
events: axonal factors and components of the ECM. In particular, the type III isoform of Neuregulin1 on the axon surface and
laminin-2 in the basal lamina are required for Schwann cells to
segregate and myelinate axons properly (Bunge et al., 1986;
Nave and Salzer, 2006). In addition to these major extrinsic signals, several additional signals have also recently been implicated in Schwann cell development (Glenn and Talbot, 2013).
These signals activate distinct receptors and signaling pathways. Neuregulin1 binds to the erbB2 and erbB3 coreceptors on
© 2014 Heller et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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the inner (i.e., the adaxonal) Schwann cell membrane (Canoll
et al., 1996; Vartanian et al., 1997; Michailov et al., 2004).
Neuregulin1-bound erbB2/3 activates PI 3-kinase (PI 3-K),
among other pathways implicated in Schwann cell myelination
(Maurel and Salzer, 2000; Kao et al., 2009; Newbern et al.,
2011). In contrast, laminin receptors such as integrins and dystroglycan are present on the outer (i.e., the abaxonal) membrane
(Einheber et al., 1993; Feltri et al., 1994; Saito et al., 2003). The
61 integrin has been shown to signal through Rac, focal adhesion kinase (FAK), and potentially integrin-linked kinase (ILK),
in the radial sorting of axons before myelination (Feltri et al.,
2002; Grove et al., 2007; Nodari et al., 2007; Pereira et al., 2009).
As myelination proceeds, the 64 integrin and dystroglycan
predominate and may function to stabilize myelin (Nodari et al.,
2008). 64 can activate several downstream pathways including
PI 3-K (Giancotti, 2007); the precise role of this integrin in mediating signaling in the PNS has not been examined.
In this study, we have focused on the PI 3-K pathway,
which generates the signaling intermediates phosphatidylinositol biphosphate (PI-3,4-P2) and triphosphate (PI-3,4,5-P3) at
the membrane (Cantley, 2002). PI 3-K activity is opposed by
the lipid phosphatase and tensin homologue (PTEN), which hydrolyzes these phosphatidylinositols (Maehama and Dixon,
1998). The importance of this pathway in myelination is underscored by studies in which conditional ablation of PTEN in myelinating glia was shown to result in hypermyelination (Goebbels
et al., 2010). Conversely, pharmacological inhibition PI 3-K signaling blocks myelination initiation (Maurel and Salzer, 2000).
Although PI 3-K is critical for myelination, its temporal
activation and its various downstream effectors are incompletely
characterized. Many signaling molecules in the PI 3-K pathway
are activated by phosphatidylinositol-dependent kinase1 (PDK1),
which binds PI-3,4-P2 and PI-3,4,5-P3 in the plasma membrane
(Alessi et al., 1997a). Two well-described examples are Akt and
Sgk (serum and glucocorticoid-induced kinase; Mora et al.,
2004). These closely related serine–threonine kinase families
both have three isoforms and share a substrate recognition motif
(RXRXX*S/T) with each other and with the p70 and p90 ribosomal S6 kinases (Alessi et al., 1996; Kobayashi et al., 1999).
Generation of antibodies against this sequence has facilitated
investigations of the spatial and temporal expression of PI 3-K
effectors (Kane et al., 2002; Kamimura et al., 2008).
Here we use this phospho-substrate antibody to characterize PI 3-K pathways and their effectors during myelination. Our
findings support a model in which Neuregulin1 on the axon
drives activation of Akt and thereby the mammalian target of
rapamycin (mTOR) pathway in Schwann cells at the onset of
myelination. Subsequently, laminin in the ECM activates Sgk1
via the 64 integrin, resulting in the phosphorylation of
NDRG1 (N-myc downstream-regulated gene1), a Schwann cell
phospho-protein critical for myelin stability (Kalaydjieva et al.,
2000; Okuda et al., 2004). Phospho-NDRG1 is highly expressed in the Cajal bands of the abaxonal compartment, implicating these cytoplasmic channels as focal sites of integrin
signaling. Unexpectedly, loss of either 4 integrin signaling or
of Sgk1 enhances myelination during development. These
results demonstrate a spatiotemporal progression of PI 3-K
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signaling from a pro-myelinating, Neuregulin1-dependent pathway to a laminin–integrin–Sgk1 pathway that negatively regulates PNS myelination.

Results
PI 3-K signaling substrates are distinctly
regulated with myelination

To monitor the activity of the PI 3-K pathway during myelination, we used an antibody raised against the phosphorylated substrate recognition motif for a subset of AGC kinases (i.e., Akt,
Sgk, p90 RSK, and p70 S6K; Zhang et al., 2002). We stained myelinating co-cultures of sensory neurons and Schwann cells with
this antibody to localize putative PI 3-K substrates (Fig. 1). Every
myelinating Schwann cell, identified by their expression of myelin
basic protein (MBP), was robustly stained by the phospho-substrate
(p-Sub) antibody along the length of the sheath. Phospho-substrates
were also enriched in the Schmidt-Lanterman incisures (SLI;
Fig. 1 C) and in the paranodes (Fig. 1 D), suggesting these regions
are also foci of PI 3-K activity.
As all Schwann cells in these cultures were associated with
axons but only myelinating Schwann cells were strongly stained,
axonal contact is not sufficient to up-regulate these phosphosubstrates. A subset of premyelinating Schwann cells that had
elongated along the axon but expressed little if any MBP were
also positively stained (Fig. 1 A, arrowheads in magnified insets).
Premyelinating Schwann cells were identified by their expression
of Oct-6/POU3F1, a transcription factor transiently up-regulated
just before myelination (Fig. 1 B; Bermingham et al., 1996;
Jaegle et al., 2003). Quantification of one set of cultures revealed
that 10% (n = 154) of the premyelinating (POU3F1+/MBP)
cells were also stained by the p-Sub antibody. These results indicate that one or more phospho-substrates are up-regulated just
before formation of compact myelin.
To further characterize the temporal expression of phosphosubstrates, we used the p-Sub antibody to probe lysates from
co-cultures that had myelinated for different times. These blots
revealed a discrete number of bands (Fig. 2 A), most of which
were up-regulated with myelination, indicated by increased
myelin protein zero (P0) expression; this up-regulation is consistent with the increase in staining with the same antibody at
the onset of myelination (Fig. 1 A). The most prominently upregulated band is a doublet of 45 kD. In contrast, at least two
phospho-proteins of 30 and 250 kD were down-regulated
with myelination. Expression of these bands was also detected
at lower levels in neuron-only and Schwann cell–only cultures,
respectively (unpublished data).
These results suggest expression of these, and other phosphoproteins in Schwann cells, neurons, or both were altered as a consequence of axon–glial interactions. To determine if prolonged
axon–Schwann cell interactions were sufficient to modulate their
expression or myelination was required, we co-cultured Schwann
cells and neurons together for 35 d in the presence or absence
of ascorbate, which is required for myelination (Eldridge et al.,
1987). We blotted the lysates with the p-Sub antibody, using p45
and p30 as representative substrates that are up-regulated and
down-regulated, respectively (Fig. 2 B). Only the myelinated

Figure 1. Phospho-substrates are up-regulated with myelination. (A) Myelinating co-cultures of rat sensory neurons and Schwann cells stained for
MBP (red), p-Sub (green), and laminin (white); boxed areas are shown at higher magnification below at 1.5×. Myelinating Schwann cells (inset, arrow)
are selectively stained with the phospho-substrate antibody (p-Sub). Some Schwann cells that have elongated but are not yet expressing MBP at significant levels are stained with the p-Sub antibody (arrowheads). Bar, 75 µm. (B) Staining of myelinating co-cultures for p-Sub (green), POU3F1 (red),
and MBP (blue) is shown. A subset of premyelinating POU3F1-expressing Schwann cells coexpress phospho-substrates (arrow). All MBP-expressing
Schwann cells, which are POU3F1-negative, coexpress phospho-substrates (arrowheads). Bar, 10 µm. (C) Myelinating co-cultures stained with p-Sub
(green), Mupp1 (red), and MBP (blue) indicate that phospho-substrates are enriched in the SLI. Bar, 5 µm. (D) Myelinating co-cultures stained with p-Sub
(green), Caspr1 (red), and MBP (blue) indicate that phospho-substrates are sometimes enriched in the distal glial paranode (arrow), extending into the
juxtaparanode (arrowhead). Bar, 5 µm.

cultures exhibited the characteristic up-regulation of p45 and
down-regulation of p30, suggesting that myelination regulates
either their expression and/or their phosphorylation.
Identification of phospho-substrate
proteins

To identify the p30 and p45 proteins, we took a candidate approach
based on previous reports using the p-Sub antibody (Kane et al.,
2002). We first examined whether p45 might correspond to

phosphorylated N-myc downstream–regulated gene 1 (NDRG1),
a protein of similar size that is phosphorylated at several sites,
including Ser330 and Thr346/Thr356/Thr366 (3xThr; Murray
et al., 2004). We used the p-Sub antibody to blot lysates from
stretcher nerves, which express minimal levels of truncated
NDRG1 and no full-length protein (King et al., 2011). p45 was
undetectable in the stretcher nerve lysates (Fig. 3 A), confirming
that this band corresponds to NDRG1. We also stained myelinating organotypic cultures prepared from wild-type and stretcher
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Figure 2. Phospho-substrates are differentially expressed during myelination. (A) Time
course of the expression of phospho-substrates
in myelinating co-cultures. Western blot analysis of lysates prepared from co-cultures beginning on day 0, when myelinating media was
added, through day 21. Six major bands were
detected that either increased or decreased
as myelination proceeded. The p-Sub reactive
bands are in red, -actin in green; P0 myelin
protein expression is also shown. (B) Co-cultures
of Schwann cells and sensory neurons were
maintained for 35 d under nonmyelinating
(NM) or myelinating (Myel.) conditions. The increase in p45 and decrease in p30 observed
in the time course shown in A only occur under
myelinating conditions.

mice with the p-Sub and three NDRG1-specific antibodies
(Berger et al., 2004; Sommer et al., 2013). We found that total
and phospho-specific NDRG1 antibodies only stained the wildtype but not the stretcher cultures, indicating these antibodies
are specific for NDRG1 (Fig. S1 A). In contrast, although staining of stretcher cultures with the p-Sub staining antibody was
reduced, notably in the abaxon (Fig. S1 B), it was not abolished.
These latter data show that NDRG1 is a major but not the only
phosphorylated substrate in myelinating Schwann cells detected
by the p-Sub antibody (Fig. 1 A).
We considered whether p30 is the S6 ribosomal protein
(S6rp), a protein of similar molecular weight that is phosphorylated by S6 kinase and is downstream of Akt and mTOR signaling (Magnuson et al., 2012). We treated nonmyelinating
co-cultures with inhibitors of PI 3-K (LY294002), mTor/TORC1
(rapamycin), and S6 kinase (PF4708671) for 18 h. Each inhibitor abolished p30 phosphorylation (Fig. 3 B), confirming that
this band is p-S6rp.
Expression and localization of phosphosubstrate proteins during myelination

We next examined the time course of Akt, S6rp, and NDRG1
phosphorylation during sciatic nerve development by Western
blotting (Fig. 3 C). Based on Akt phosphorylation, PI 3-K is most
active early in development and decreases as myelination proceeds. Phosphorylation of both Akt sites (i.e., T308, the PDK1
phosphorylation site, and S473, the TORC2 phosphorylation site;
Alessi et al., 1997b; Sarbassov et al., 2005) is down-regulated
with myelination. Similarly, S6rp is highly phosphorylated early
and then down-regulated. The decrease in p-Akt and p-S6rp levels may also result from the decrease in total Akt and S6rp levels
that accompanies myelination. In contrast, phospho- and total
NDRG1 levels are robustly up-regulated with myelination. These
data suggest that an early-acting PI 3-K pathway drives Akt and
S6rp signaling and a late-acting PI 3-K pathway regulates NDRG1
phosphorylation, potentially independent of Akt.
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To elucidate where in the Schwann cell these signaling
events were localized, we stained myelinating co-cultures for
p-Akt, p-S6rp, and p-NDRG1. The localization of p-Akt (S473)
depended on the maturity of the myelin sheath (Fig. 4 A); it was
initially localized along the length of the myelinating Schwann cell
but concentrated at the paranodes as the sheath matured. Thus,
at five days in myelinating media, premyelinating and nascent
myelinating Schwann cells expressed p-Akt along the length of
their processes. As myelination proceeded, p-Akt was localized
to the paranodes of mature myelin sheaths, identified by expression of Caspr; p-Akt also was similarly localized in neonatal
sciatic nerves (Fig. S1 C). This staining was specific, as it was
lost when co-cultures were pretreated for 24 h with the PI 3-K
inhibitor LY294002.
Staining of p-S6rp only partially overlapped with p-Akt.
p-S6rp was most robustly expressed in nonmyelinating and
23% (n = 172) of premyelinating (POU3F1+/MBP) Schwann
cells (Fig. 4 B). Only a few MBP+ Schwann cells (3%) expressed p-S6rp, and these were weakly stained (an example is
marked by an asterisk in Fig. 4 B). These data are consistent
with Western blotting results showing that S6rp is downregulated with myelination (Fig. 2 B and Fig. 3 C). The p-S6rp
staining was present in the soma of premyelinating Schwann
cells and in their processes that extended along and ensheathed
neurites; no staining within neurites was detected.
Total and phosphorylated NDRG1 appeared to be enriched
in the abaxon of myelinating Schwann cells (Fig. 4 C). Similar to
p-Sub, we observed an occasional enrichment to the paranode in
which p-Akt is localized. Taken together, these data suggest that
p-Akt and p-S6rp are expressed at an early stage of axon–Schwann
cell contact, whereas NDRG1 is downstream of a distinct pathway that is activated later in the abaxonal compartment.
To determine whether p-NDRG1 is indeed concentrated
in the abaxonal compartment, we performed immunoelectron
microscopy of myelinating co-cultures (Fig. S2, A and B). For
immuno-EM, the numbers of gold particles in the abaxonal,

Figure 3. S6rp and NDRG1 correspond to
the 30- and 45-kD phospho-substrate bands.
(A) Western blots of wild-type and stretcher
sciatic nerve lysates were probed with antiNDRG1 and p-Sub antibodies; -actin serves
as a loading control. NDRG1 and the p45-kD
p-Sub doublet are not detected in the stretcher
nerve lysates. (B) Western blots of lysates from
nonmyelinating co-cultures were treated with
50 nM rapamycin, 20 µM LY294002, or 40 µM
PF-4708671 for 18 h and then probed with
p-Sub, p-S6rp, and total S6rp antibodies.
p-S6rp and p30 are not detectable in cocultures treated with rapamycin, LY294002, or
PF-4708671. (C) Expression of phospho- and
total Akt, NDRG1, and S6rp in developing
rat sciatic nerves. Lysates of postnatal sciatic
nerves were probed on Western blots with
the indicated antibodies. Both total and phosphorylated NDRG1 are up-regulated in parallel with compact myelin proteins P0 and MBP.
S6rp and Akt are maximally expressed and
phosphorylated early, then down-regulated as
myelination proceeds.

adaxonal, and compact myelin compartments were determined
in a blinded manner. Localization in each compartment was represented as a percentage of total particles counted in all three
compartments. Myelin-associated glycoprotein and MBP served
as controls for proteins expressed in the adaxon and in compact
myelin, respectively. Analysis revealed more gold particles for
phosphorylated NDRG1 (S330) in the abaxon than in compact
myelin or the adaxon, supporting an abaxonal localization.
We also stained adult teased nerve fibers for total and
p-NDRG1 (3xThr) and with antibodies to Necl–4, a marker of
the Schwann cell periaxonal membrane and clefts (Maurel
et al., 2007; Spiegel et al., 2007) and to -dystroglycan (-DG),
a laminin receptor exclusive to the abaxonal Schwann cell membrane. Total NDRG1 was present in the adaxonal compartment,
in the SLI, and in the abaxonal compartment (Fig. 5 A). In contrast, p-NDRG1 was present only in the outer aspect of the SLI
and in the abaxonal compartment (Fig. 5 B); no adaxonal staining was observed. By imaging the surface of the nerve fibers
(Fig. 5, C and D), we determined that both total and p-NDRG1
are enriched in the Cajal bands (i.e., the cytoplasmic channels
that form between -DG–positive appositions in the abaxonal
compartment). Taken together, these data indicate that total and
phosphorylated NDRG1 are enriched in the Cajal bands and
clefts. Although total NDRG1 is present in the adaxonal compartment, as previously reported (Berger et al., 2004), it is not
phosphorylated in this site.
S6rp is a substrate of Neuregulin1 type III
signaling; NDRG1 is a substrate of
laminin signaling

The distinct spatial and temporal patterns of p-S6rp and NDRG1
phosphorylation suggest that they are activated by different
signals. We therefore compared substrate phosphorylation of
NDRG1 and S6rp in two in vivo mouse models: (1) Neuregulin1
type III haploinsufficient mice (Nrg1+/), and (2) laminin-2–null

(dy3k/dy3k) mice (blots shown in Fig. 6 A, quantification in Fig. 6 B).
Nerves were analyzed at P10 when both NDRG1 and S6rp are
normally robustly phosphorylated (Fig. 3 C). Mice haploinsufficient for type III Neuregulin1, which are known to be hypomyelinated (Michailov et al., 2004; Taveggia et al., 2005), had
reduced levels of p-Akt (T308) and of p-S6rp but normal levels of p-NDRG1. Similarly, p-S6rp is virtually undetectable in
Schwann cells co-cultured under myelinating conditions with
Neuregulin1 type III–null sensory neurons relative to their
wild-type counterparts (Fig. S2 C). In contrast, p-NDRG1 was
decreased dramatically in the dy3k/dy3k mice, in addition to a
modest reduction in p-S6rp levels. Thus, S6rp phosphorylation
is driven by Neuregulin1 and potentially by laminin, whereas
NDRG1 phosphorylation is primarily laminin dependent.
NDRG1 phosphorylation is dependent on
laminin receptors

These data indicate laminin is necessary for NDRG1 phosphory
lation. To determine whether it is also sufficient, we applied
laminin, with or without the LY inhibitor, for 30 min to serumstarved cultures of pure Schwann cells or co-cultures of Schwann
cells and sensory neurons (Fig. S3, A and B). Addition of laminin resulted in robust NDRG1 phosphorylation only in Schwann
cells co-cultured with neurons; there was no increase when laminin was added to Schwann cells cultured alone. The application
of soluble Neuregulin1 type III also up-regulated NDRG1 phosphorylation in nonmyelinating cultures, suggesting that signaling is not compartmentalized before the formation of the abaxon
and adaxon (Fig. S3 C). These data indicate that the signaling
pathway(s) that drive NDRG1 phosphorylation downstream of
laminin require axonal contact.
We next examined the role of Schwann cell laminin receptors in transducing the phosphorylation signal, focusing on the
61 and 64 integrins. Both integrins are expressed on the
abaxonal membrane of Schwann cells; 64 expression is axon
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Figure 4. Localization of p-S6rp, p-NDRG1, and p-Akt in myelinating co-cultures. (A) Co-cultures maintained in myelinating media for 5 or 14 d were
stained for p-Akt (green), Caspr (red), and MBP (blue). In 5-d co-cultures (top row), Schwann cells just before myelinating express p-Akt (S473) along their
length; Caspr staining of axons is diffuse and MBP is not yet expressed. In 14-d co-cultures (bottom two rows), p-Akt staining varied depending on the maturity of the myelin segments. In a thinly myelinated segment with a single paranode (bracket), p-Akt was prominent along the Schwann cells, in more mature
segments with two hemi-paranodes (arrows) or surrounding a mature node (arrowheads) staining was concentrated in the paranodal and juxtaparanodal
regions. Addition of the LY inhibitor before fixation abolished p-Akt staining. Bar, 20 µm. (B) Myelinating co-cultures were stained for p-S6rp (green),
POU3F1 (red), and MBP (blue). p-S6rp was maximally expressed in the cytoplasm and along the processes of a premyelinating Schwann cell expressing
POU3F1 (arrows) and at lower levels in myelinated Schwann cells (one is marked by an asterisk). Bar, 20 µm. Inset (far right panel) is at 2×. (C) Myelinating
co-cultures stained for phospho- (3xThr, S330) and total NDRG1 (all green), MBP (blue), and Caspr (red). Myelinating Schwann cells express phospho- and
total NDRG1 (green) along the outside of the myelin sheath and in some paranodes (insets, 3× magnification). Bar, 20 µm.
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Figure 5. NDRG1 is enriched in the Cajal bands of the abaxonal compartment. (A) A teased adult rat sciatic nerve fiber stained for total NDRG1 (green)
and Necl-4 (red) is shown. Total NDRG1 is present in the abaxon (green arrow), adaxon (yellow arrow), and throughout the length of the SLI (white brackets); Necl-4 is present in the adaxonal membrane and the incisures. Inset is rotated and shown at 3×. Bar, 20 µm. (B) Teased adult rat sciatic nerve fiber
stained for phospho-NDRG1 (green) and Necl-4 (red) is shown. p-NDRG1 is expressed in the abaxon (green arrow) but not the adaxon (red arrow) and
only the outer portion of the SLI (white brackets). Necl-4 is expressed throughout the entire incisures. A Cajal band is present in the center of the fiber (white
asterisks). Inset is rotated and shown at 3×. Bar, 20 µm. (C and D) Teased P45 mouse sciatic nerve fibers stained for (C) total or (D) p-NDRG1 (green)
and -dystroglycan (red); SLI are labeled with white arrowheads. Both total and p-NDRG1 are enriched in the Cajal bands and excluded from the -DG
stained appositions. Bar, 20 µm.
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Figure 6. Neuregulin1 and laminin-2 differentially regulate S6rp and NDRG1 phosphorylation. (A) Lysates of P10 nerve from Neuregulin1 type III haplo
insufficient or 2-laminin–null (dy3k/dy3k) mice were blotted for total and phosphorylated Akt, S6rp, and NDRG1. Whereas p-Akt is reduced in both nerves,
phospho-NDRG1 is markedly reduced only in the 2-laminin–null mice. (B) Quantification of the phosphoprotein levels in neuregulin and laminin mutant
nerves are shown normalized to total protein in each case. Mean ± SEM; *, P < 0.05; ***, P < 0.001 by two-tailed Student’s t test; n ≥ 3.

contact dependent and up-regulated with myelination in a pattern similar to that of NDRG1 phosphorylation; 1 persists during myelination but is maximally expressed before myelination
and by Schwann cells cultured alone (Einheber et al., 1993;
Feltri et al., 1994). Floxed alleles of the 1 and 4 integrin subunits, and of -DG were conditionally ablated in Schwann cells
beginning at E15 using the P0 Cre driver line (Feltri et al.,
1999). Nerves from the P0 Cre driver line served as a control.
We analyzed NDRG1 phosphorylation in lysates of P10
nerves deficient in each of these laminin receptors (Fig. 7 A and
Fig. S4 A). Nerves deficient in -DG exhibited a modest reduction of NDRG1 phosphorylation at both sites. A more significant reduction was observed in the 1 and 4 integrin conditional
nulls but only at Ser330. This latter result suggests that there
may be compensatory mechanisms in the integrin nulls that rescue downstream signaling of the p-3xThr site. To test this possibility, we examined a loss-of-function knock-in mouse model in
which 4 integrin is missing its canonical signaling domain;
this mutant is expressed at physiological levels, heterodimerizes
with the 6 subunit, and binds to laminin properly (Nikolopoulos
et al., 2004). NDRG1 phosphorylation was significantly reduced
at both sites in the 4 integrin signaling mutant. These data suggest that there are cooperative effects of laminin receptors in
promoting NDRG1 phosphorylation, with a key role of 4 integrin in transducing the laminin signal to NDRG1. Importantly,
phosphorylation of S6rp is not significantly reduced in the 4
integrin–signaling mutant (Fig. 7 B and Fig. S4 B) indicating its
phosphorylation is distinctly regulated from NDRG1 and is not
primarily downstream of matrix–integrin interactions.
Akt1 and Sgk1 contribute to
NDRG1 phosphorylation

To determine the kinases downstream of 4 integrin, and other
laminin receptors, that phosphorylate NDRG1 we took a candidate approach. Sgk1 has been proposed to be the primary
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NDRG1 kinase, although recent data suggest that Akt may also
play a role (Burchfield et al., 2004; Murray et al., 2004; Sommer
et al., 2013). We therefore examined NDRG1 phosphorylation
in P10 and adult knockout nerves from Sgk1- and Sgk3-null
animals; these two Sgk isoforms are the sole isoforms expressed
in Schwann cells based upon RT-PCR analysis (Fig. 8 A). We
found a major reduction in NDRG1 phosphorylation at the 3xThr
sites in the Sgk1 knockout nerves at P10 and at all sites (S330,
3xThr) in the adult (Fig. 8 B and Fig. S4 C). Sgk3 knockout
nerves also showed a reduction of phosphorylation at the 3xThr
sites. These data provide strong support for an important but not
an exclusive role of Sgk1 in NDRG1 phosphorylation.
Because phosphorylation at S330 was not reduced in either Sgk-null mice at P10, we examined NDRG1 phosphorylation in the Akt1, 2, and 3 knockout nerves (Fig. S4 D). Loss of
Akt1, but not of Akt2 or 3, decreased p-S330 but not p-3xThr.
Therefore, both Akt1 and Sgk1 contribute to NDRG1 phosphory
lation during development, whereas Sgk1 and Sgk3 are the major
NDRG1 kinases in the adult.
Loss of 4 integrin signaling and Sgk1
enhance myelination during development

These studies suggest that Sgk1 is an important regulator of
NDRG1 phosphorylation in myelinating Schwann cells. Although Sgk1-null mice develop normally and do not exhibit any
overt neurological phenotype, the role of Sgk1 in myelination
has not been specifically examined (Wulff et al., 2002; FejesTóth et al., 2008). To address its function in myelination directly, we analyzed P10 sciatic nerve from Sgk1-null, heterozygous,
and wild-type siblings by EM (Fig. 9). Sgk1-null nerves appeared normal, but on close inspection exhibited thicker myelin
sheaths on average than their wild-type littermates (Fig. 9 A).
This was confirmed by the reduced g-ratios in the knockout
mice, in which there is a dose-dependent effect of Sgk1 as
heterozygotes had g-ratios intermediate between wild-type

Figure 7. 4 integrin is a key laminin receptor upstream of NDRG1 phosphorylation.
(A) Lysates from P10 nerves deficient in various
laminin receptors were probed for alterations
in NDRG1 phosphorylation at the p-S330 and
p-3xThr sites. p-NDRG1 levels are normalized to total NDRG1 for each quantification.
Conditional ablation of the 1 (n = 3) and 4
(n = 4) integrin subunit causes a defect on S330
phosphorylation but not p-3xThr. The signaling-defective 4 mutant (4/; n = 7) exhibits
a marked reduction of phosphorylation at both
the S330 and 3xThr sites. The DG-null has
a small but significant defect at both S330
and 3xThr (n = 5). Mean ± SEM; *, P ≤ 0.05;
**, P < 0.01; ***, P < 0.001 by two-tailed
t test. (B) P10 4-signaling mutant nerves have
normal levels of S6rp phosphorylation. Quantifications were normalized to total S6rp protein
levels. Mean ± SEM; n = 4; P > 0.05 by twotailed t test.

and knockout nerves (Fig. 9 E). This effect is most evident in
small- and medium-caliber axons (Fig. 9 F).
Additional abnormalities observed in the Sgk1 nulls included more complete sorting of larger-caliber axons compared with controls. Thus, there were 15 unsorted axons larger
than 1.1 µm in diameter among the 50 fields of wild-type
nerves examined (Fig. 9 B); all axons of this size were sorted
in 50 fields of Sgk1 nulls. There were also twice as many
smaller-caliber axons (i.e., less than 0.9 µm in diameter) that
were myelinated in the Sgk1 nulls relative to the wild types,
and these tended to be hypermyelinated (P > 0.05). Finally, we
also observed examples of polyaxonal myelination, i.e., multiple small-caliber axons that were myelinated in common by
a single Schwann cell, in the Sgk1 nulls (Fig. 9 C); none were
observed in the wild-type or heterozygote mice. No abnormalities of Remak fibers were observed in the nulls, indicating the
defects are specific to myelinated fibers. Taken together, these
findings indicate that radial sorting is accelerated and myelin
sheath thickness increased in Sgk1-null nerve at P10, implicating Sgk1 as a negative regulator of myelination during
early development.
Because Sgk1 signals downstream of 64, we also examined myelination in the 4-signaling mutant mice. These mice
also demonstrated modest hypermyelination (Fig. 9 D; quantified
in Fig. S5 A), which was most evident in fibers of medium diameter (1.5–2.5 µm).
Taken together, these results unexpectedly implicate integrin signaling from the matrix via PI 3-K/Sgk1 as an inhibitor of myelination. Several proteins have been identified as
negative regulators of PI 3-K/Akt signaling (i.e., DLG1, PTEN,
and REDD1; Cotter et al., 2010; Noseda et al., 2013). We therefore examined whether their expression was altered in Sgk1null nerves (Fig. S5 B). We found that none of these molecules
were significantly altered. Whereas REDD1 levels were modestly reduced, mTOR activity (indicated by p-S6rp levels), its
negatively regulated effector, was not consistently increased.
These results suggest that the mechanism(s) by which 4 integrin and Sgk1 down-regulate myelination may involve other
signaling pathways.

Discussion
Schwann cell myelination depends on a discrete number of extrinsic signals originating from the axon and the ECM (Pereira
et al., 2012; Salzer, 2012; Glenn and Talbot, 2013). These signals, in turn, activate a complex set of intracellular pathways.
Elucidating the effectors of these pathways, and determining
the sites where they act, will be essential to an understanding of
how these ligands and pathways cooperate to promote myelin
assembly. Here, we have characterized further the PI 3-K pathway during myelination. Our studies indicate that PI 3-K is
transiently activated by Neuregulin1 at the onset of myelination, driving the Akt/mTOR pathway; subsequently, PI 3-K is
activated by laminin as the sheath matures, activating Sgk1 and
inhibiting myelination (Fig. 10). Our data further suggests these
pathways are spatially segregated. These findings are considered further below.
Neuregulin1 signaling is the main activator
of mTOR at the onset of myelination

We previously demonstrated that type III Neuregulin1 is the key
signal on the axon that activates PI 3-K, which in turn is essential for myelination (Maurel and Salzer, 2000; Taveggia et al.,
2005). Here we demonstrate that type III Neuregulin1 on the
axon is also the major driver of TORC1 activation, based on
p-S6rp levels. During initial interactions, p-Akt is present along
the length of the elongated, premyelinating Schwann cells
(Fig. 4 A) in direct apposition to the axon and thus Neuregulin1.
Similarly, p-S6rp is present in the ensheathing processes of premyelinating Schwann cells (Fig. 4 B). p-S6rp levels are activated in concert with p-Akt and well before the peak of laminin
signaling indicated by NDRG1 phosphorylation (Fig. 3 C). Finally, genetically reducing or ablating Neuregulin1 in vivo and
in vitro resulted in reduced activation of p-Akt and p-S6rp (Fig. 6
and Fig. S2 C).
There may also be a modest, supplemental role of laminin–
integrin signaling in the activation of PI 3-K/Akt/mTOR in myelinating Schwann cells. p-S6rp levels are somewhat reduced in
laminin-deficient mice at P10 (Fig. 6). This may be a direct effect

PI 3-kinase pathways differentially regulate myelination • Heller et al.

1227

Figure 8. Sgk isoforms phosphorylate NDRG1. (A) RT-PCR of first-strand cDNA obtained from pure sensory neurons, Schwann cells, and kidney (control)
using Sgk isoform-specific primers demonstrates Sgk1 and Sgk3 are expressed by Schwann cells. (B) Quantification of Western blots analyzing phosphorylation at the p-S330 and 3xThr sites of NDRG1 in P10 and adult (P60) sciatic nerves from Sgk1- or Sgk3-specific knockouts. Sgk1 loss of function reduces
NDRG1 phosphorylation at the 3xThr site at P10 and at both sites in the adult. Sgk3 loss of function slightly increases p-S330 and decreases 3xThr in the
adult. p-NDRG1 was normalized to total NDRG1, which was similar across phenotypes, for the quantification. Mean fold change relative to wild type ±
SEM, n ≥ 4. *, P < 0.05; ***, P < 0.001 by two-tailed Student’s t test.

of laminin or, alternatively may reflect its role in promoting
Schwann cell ensheathment of axons and thereby erbB receptor phosphorylation and PI 3-K/Akt/mTOR activation (Yu et al.,
2005; Berti et al., 2011). The former possibility is suggested
by the slight reduction of p-S6rp in the 4 integrin–signaling
mutant at P10 (Fig. 7 B), although this did not reach statistical
significance. In addition, p-S6rp is detected at low levels in the
soma of some myelinating Schwann cells (Fig. 4 B) in culture
and in the adult mouse (Sherman et al., 2012), consistent with
direct activation in the abaxonal compartment downstream of
laminin. Taken together, these data indicate that Neuregulin1 on the
axon is the major regulator of S6rp phosphorylation and TORC1
activity during development; however, once myelination is complete, laminin signaling may contribute to low-level activation.
mTOR has a key role during PNS myelination based on
conditional knockouts of mTOR in embryonic Schwann cells,
which exhibit thin, short myelin sheaths (Sherman et al., 2012).
These results further implicate the Neuregulin1/PI 3-K/Akt/
mTOR pathway in the radial and longitudinal expansion of the
myelin sheath. They also suggest that the hypomyelination observed in mice haploinsufficient for Neuregulin1 (Michailov
et al., 2004; Taveggia et al., 2005) likely results, in part, from
reduced mTOR activity. The precise role(s) of mTOR during
myelination remains to be established but may reflect its key
role in regulating protein translation (Laplante and Sabatini,
2013), potentially including translation of proteins required for
myelination. Indeed, the expression of p-S6rp in ensheathing
processes (Fig. 4 B) is appropriately localized to regulate local
translation at the onset of myelin biosynthesis.
Spatiotemporal changes in PI 3-kinase
signaling during myelination

As myelination proceeds, PI 3-K activity progressively decreases (Fig. 3 C), including along the internode (Fig. 4 A).
This reduction is consistent with the limited effects of inhibiting
PI 3-K after myelination is established (Maurel and Salzer,
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2000) and of ablating Neuregulin1 and erbB2 in the adult
(Atanasoski et al., 2006; Fricker et al., 2009). Thus, although
activation of PI 3-K by Neuregulin1 is critical for the initial
events of myelination, it is dispensable for myelin maintenance.
The decline in p-Akt activity along the internode may be multifactorial. One mechanism is the recruitment of PTEN to the
adaxonal compartment, where it interacts with and is likely
stabilized by DLG1 (Ozçelik et al., 2010; Sandoval et al., 2013).
In addition, we have found that total Akt levels are substantially
down-regulated during myelination (Fig. 3 C), likely further
limiting signaling.
The reduction of p-Akt along the internode is accompanied by its enrichment within the paranodes in vitro and in vivo
during active myelination (Fig. 3 C, Fig. 4 A, and Fig. S1 A).
Enrichment of p-Akt in the paranodes was also observed in
PTEN-conditional mice, which exhibit markedly elevated PI
3-K activity (Goebbels et al., 2010), and is consistent with localization of phospho-substrates at this site (Fig. 1 D). Akt may
be activated in the paranodes as the result of converging signals
from adaxonal erbB receptors and abaxonal laminin receptors.
In addition, the autotypic adherens junctions, which form between the paranodal loops themselves, may be another source
of PI 3-K activity (Fannon et al., 1995; Rivard, 2009). Enrichment of phospho-substrates in the SLI (Fig. 1 C and Fig. 5) further supports the clefts as a locus of PI 3-K signaling.
Phospho-NDRG1 localization implicates
Cajal bands as sites of laminin and 64
integrin signaling

Both total and p-NDRG1 are dramatically up-regulated with
myelination (Fig. 3 C), consistent with a previous report (Berger
et al., 2004). These authors also reported that NDRG1 is expressed throughout the Schwann cell cytoplasm. Here, we show
both total and p-NDRG1 are strikingly enriched in the Cajal
bands, providing compelling evidence that NDRG1 is concentrated abaxonally (Fig. 5 B). The Cajal bands are anastomosing

Figure 9. Sgk1-null mice are hypermyelinated during development. (A) Representative electron microscopic fields of P10 nerves from wild-type and
Sgk1/ mice are shown, demonstrating modest hypermyelination of some fibers in the null nerve. Bars, 5 µm. (B) At P10, large-caliber axons (asterisk) are
still occasionally ensheathed in the Remak bundles of wild-type but not Sgk1 knockout nerves (not depicted). Bar, 1 µm. (C) An example of multiple small
axons (asterisks) communally myelinated by a single Schwann cell from the Sgk1-null mice is shown. Bar, 1 µm. (D) Representative electron microscopic
fields of P10 nerves from wild-type and 4-signaling mutant mice are shown, demonstrating modest hypermyelination of some fibers in the mutant nerve.
Bars, 5 µm. (E) Quantification of the g-ratios in P10 nerves from wild-type (884 axons scored), Sgk1+/ (942 axons scored), and Sgk1/ (796 axons
scored) mice. Loss of Sgk1 results in a modest hypermyelination that is dose dependent. Mean g-ratios are shown ± SEM; **, P < 0.01; ****, P < 0.0001
by ANOVA. (F) Quantification of the g-ratios in P10 nerves from wild type, Sgk1+/, and Sgk1/ binned by axon caliber. Mean g-ratios are shown ±
SEM; ***, P < 0.001; ****, P < 0.0001 by ANOVA and Tukey’s multiple comparisons test.
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Figure 10. Schematic of PI 3-K pathways activated during myelination. Schematic of the proposed transition in PI 3-K during myelination. In premyelinating Schwann cells (left), Neuregulin1 drives myelination by activating TORC1 through erbB-dependent PI 3-K/Akt activation. In myelinating Schwann cells
(right), pro-myelinating signals are opposed by laminin signaling via 64 integrin and Sgk1. This signaling is localized to the Cajal bands of the abaxon;
among the targets of Sgk1 phosphorylation is NDRG1, a protein required for long-term myelin maintenance.

cytoplasmic channels interposed between -DG–positive appositions that form between the outer Schwann cell membrane and
the compact myelin sheath (Sherman and Brophy, 2005). Although their precise function is not known, the Cajal bands are
thought to provide a conduit for the centrifugal transport of
proteins and RNA from the perinuclear region (Gould and
Mattingly, 1990; Court et al., 2004).
This abaxonal localization is consistent with the dependence of NDRG1 phosphorylation on laminin-2 and laminin receptor signaling. Both 1 and 4 integrins contribute to the PI
3-K signaling upstream of NDRG1 as phosphorylation at the
S330 site was markedly reduced in the respective knockouts
(Fig. 7 and Fig. S4). Of note, 1 integrin is enriched in the outer
Schwann cell membrane immediately overlying Cajal bands
and 4 is present throughout the abaxonal membrane, including
overlying the Cajal bands (Nodari et al., 2008; Court et al.,
2011). 1 may activate PI 3-K by activating focal adhesion kinase and/or integrin-linked kinase (Reiske et al., 1999; Troussard
et al., 2003), both of which play key roles in myelination (Grove
et al., 2007; Pereira et al., 2009). However, the reduced phosphorylation of NDRG1 in the 1 knockout mice may be indirect—the result of aberrant myelination in these mice (Feltri
et al., 2002), which would be expected to impair expression of
both NDRG1 and 4 integrin.
We consider 4 the likely signaling receptor upstream of
NDRG1. 4, which is obligately associated with 6, is dramatically up-regulated in Schwann cells at the onset of myelination
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in vivo and in vitro (Einheber et al., 1993; Feltri et al., 1994) with
a time course and localization similar to that shown here for
p-NDRG1. Further, phosphorylation of NDRG1, but not of S6rp, is
markedly reduced in the 4 signaling mutant (Fig. 7). This truncated mutant lacks a cytoplasmic domain required for the activation of a number of downstream pathways, including PI 3-K (Guo
et al., 2006; Giancotti, 2007). Unexpectedly, reduction of NDRG1
phosphorylation was more robust in the 4 signaling mutant than
in the 4 knockout, as both the 3xThr and S330 sites were affected in the former. This may reflect compensation in 4 knockouts, including up-regulation of the 1 integrin subunit (Spinardi
et al., 1995; Nodari et al., 2008), which does not occur in the
knock-in signaling mutant. Alternatively, the signaling mutant
may function in a dominant-negative manner.
Sgk1 is downstream of laminin-4
integrin signaling

We have used NDRG1 to monitor signaling downstream of
laminin and laminin receptors. Sgk1 has been thought to be the
primary NDRG1 kinase; indeed, NDRG1 is widely used as a
readout of Sgk1 activity (Pearce et al., 2011; Thomanetz et al.,
2013). Consistent with this, NDRG1 phosphorylation is substantially reduced at both S330 and 3xThr in the Sgk1-null adult
nerve (Fig. 8). But in the P10 nerve, Akt1 and Sgk1 both contribute to NDRG1 phosphorylation acting on the S330 and
3xThr sites, respectively (Fig. 8 and Fig. S5). These results
indicate that Sgk1 is not the exclusive NDRG1 kinase and are

consistent with a recent report that altered Akt or Sgk expression results in compensatory changes in NDRG1 phosphorylation (Sommer et al., 2013). Taken together, these studies indicate
that Akt1 and Sgk1 are expressed and phosphorylate NDRG1 in
the developing peripheral nerve, whereas Sgk1 is the predominant NDRG1 kinase in the adult.
Two related questions concern the function of NDRG1
in myelination and the consequences of phosphorylation on its
function. In addition to Schwann cells, NDRG1 is widely expressed by many types of cells. It has been extensively studied
as a metastasis suppressor that promotes differentiation and
antagonizes cell cycle progression (Melotte et al., 2010; Bae
et al., 2013). However, the most important phenotype exhibited by NDRG1 nulls is a demyelinating neuropathy (Okuda
et al., 2004; King et al., 2011), i.e., Charcot Marie Tooth 4D
(Kalaydjieva et al., 2000). The requirement for NDRG1 in
myelin maintenance and its localization to the Cajal bands
raises the possibility these structures may also contribute to
myelin maintenance. In the future, it will be of interest to determine whether loss of NDRG1 affects transport, signaling,
and/or maintenance of the Cajal bands.
Our results suggest that NDRG1 phosphorylation may be
dispensable for its function in myelination. In the Sgk1-null and
4 signaling mutant nerves, NDRG1 phosphorylation was markedly reduced (Figs. 7 and 8) without any clear effect on myelin
stability at early ages and without an overt clinical phenotype.
Analysis of myelin structure in the adult mutant mice will be
useful to address this directly. However, even a small amount of
functional NDRG1 significantly decreases the severity of demyelination displayed in the stretcher model (King et al., 2011). Thus,
even if NDRG1 phosphorylation is necessary for its function, the
residual p-NDRG1 in the Sgk1-null nerves may be sufficient for
its role in myelin maintenance.
Spatial segregation of signaling

Our data indicate that the PI 3-K signaling pathways in the
adaxonal and abaxonal compartments are functionally distinct
and spatially segregated. There is a marked PI 3-K substrate
preference in each compartment despite the potential for communication between them provided by the paranodes and incisures (Balice-Gordon et al., 1998). Thus, loss of Neuregulin1
and laminin in the co-cultures and in vivo results in an asymmetric reduction in mTOR activation and NDRG1 phosphory
lation, respectively. Similarly, loss of 4 signaling reduces
phosphorylation of NDRG1 but not of S6rp (Fig. 7 B).
This asymmetric phosphorylation is compartment specific,
not ligand specific. In Schwann cells grown alone or under nonmyelinating co-cultures, which lack distinct cytoplasmic compartments, addition of either laminin or soluble Neuregulin1 results in
phosphorylation of both NDRG1 and S6rp (Fig. S3). In contrast,
after myelination, despite the broad expression of NDRG1, its
phosphorylation is restricted to the abaxonal compartment and
outer portions of the clefts (Fig. 5, A and B). These latter results indicate that signaling from integrins is confined to the abaxon, and
to the Cajal bands in particular. Whether other key signaling pathways are also localized to specific compartments, as seems likely
(Terada et al., 2013), will be of interest for further investigation.

Laminin-4 integrin-Sgk1 signaling
negatively regulates myelination

As laminin signals have long been considered to be promyelinating (Bunge et al., 1986), we were surprised that loss
of 4 signaling and Sgk1 enhanced myelination at P10. This
was most pronounced in the case of the Sgk1 mutants, which
exhibit a dose-dependent increase in myelin thickness, more
advanced segregation of large-caliber axons, and examples
of multiple small axons myelinated en masse by single Schwann
cells (Fig. 9). The 4 signaling mutant also exhibited evidence of hypermyelination, most evident in mid-sized fibers
(Fig. 9 D and Fig. S5 A). Of note, some of the abnormalities
in the developing Sgk1-null nerve partially phenocopy laminin and dystroglycan complex mutants. Although the most
striking defects of the 2 and 4 laminin knockouts are a
failure of radial sorting and of myelin initiation, these nerves
also display examples of hypermyelinated fibers and polyaxonal myelination, respectively (Bradley and Jenkison, 1973;
Wallquist et al., 2005). Hypermyelination of axons and polyaxonal myelination have also been observed in human dystrophic nerves (Di Muzio et al., 2003) and mice with conditional
ablation of dystroglycan or periaxin (Gillespie et al., 2000;
Saito et al., 2003). Thus, laminin and laminin-dependent pathways appear to have multiple functions during myelination—an
initial, essential role in axon wrapping in which Rac1 signaling
has been implicated (Nodari et al., 2007) and, based on these
studies, a subsequent role as a negative regulator of myelination
via Sgk1 activation.
The mechanism(s) responsible for hypermyelination in
the Sgk1 nulls is not yet known but is of significant interest.
Whether reduced phosphorylation of NDRG1 contributes, or
acts in concert with, other as yet to be identified Sgk1 targets to
mediate these effects are important questions for future study.
Identification of these Sgk1 effectors may provide novel therapeutic targets to enhance myelin repair.

Materials and methods
Neuron, Schwann cell, and myelinating co-cultures
Primary and myelinating co-cultures were established as described previously (Maurel et al., 2007). In brief, dorsal root ganglia (DRG) were removed from E16 rats or E14 mice and dissociated for 45 min with 0.25%
(vol/vol) trypsin (Life Technologies) or applied directly to pre-coated 12-mm
coverslips (Karl Hecht GmbH) for explant cultures. Unless otherwise noted,
coverslips were coated with collagen (Trevigen, Inc.). Cultures were maintained in Nunclon 4-well tissue culture plates (Thermo Fisher Scientific) at
37°C and 5% CO2. Pure neuron cultures were obtained by cycling the cultures with C-media in the presence or absence of 10 µM fluorodeoxyuridine (Sigma-Aldrich) for 2 wk; C-media is based in MEM (Life Technologies)
and contains 10% fetal calf serum (FCS; Life Technologies), 0.4% (wt/vol)
glucose (Sigma-Aldrich), 50 µg/µL 2.5S NGF (AbD Serotec), and 2 mM
l-glutamine (Life Technologies). Organotypic cultures were maintained in
C-media for two feedings before the use of C+C media (i.e., C-media with
0.05 mg/ml ascorbate; Sigma-Aldrich) to induce myelination. Neuron cultures were seeded with purified, neonatal sciatic nerve Schwann cells (1.5 ×
105 cells per coverslip; Brockes et al., 1979) to obtain a co-culture; such
cultures were maintained in C-media for nonmyelinating or C+C for myelinating conditions. Schwann cell cultures were maintained in Schwann
cell media (SC-media) that contained MEM, 10 µM l-glutamine, 10% FCS,
4 µM forskolin (LC Labs), and 5 ng/ml glial growth factor (R&D Systems).
Neurons from neuregulin1 type III mice were obtained from E13.5 timed
pregnancies, genotyped as described previously (Taveggia et al., 2005),
and maintained as described above.
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Immunofluorescence
Cultures were washed twice in phosphate-buffered saline (PBS), fixed in 4%
paraformaldehyde (Electron Microscopy Sciences) in PBS for 15 min at room
temperature (RT), and quenched in 75 mM NH4Cl (Sigma-Aldrich) and
25 mM glycine (Sigma-Aldrich) in PBS for 5 min at RT and washed once in
PBS. Fixed cultures were extracted with methanol (Thermo Fisher Scientific)
for 10 min at 20°C, then washed three times with blocking solution, which
contains 5% (wt/vol) bovine serum albumin (BSA; Sigma-Aldrich), 0.25%
(vol/vol) Tween 20 (Sigma Aldrich), and 1% (vol/vol) normal donkey serum
(Jackson ImmunoResearch Laboratories, Inc.). Primary antibodies were diluted in blocking solution, centrifuged for 10 min, then applied to the coverslips in a 30–50 µl volume overnight at 4°C. After incubation, cultures were
washed three times with PBS (5 min each), and then secondary antibodies
were applied in block for 90 min at RT. Cultures were then washed twice
with PBS, a final time in distilled water, and mounted on slides with Citifluor
(Citifluor Ltd.) with or without Hoechst (Life Technologies).
Teased sciatic nerve fibers were prepared from mouse or rat sciatic
nerve as noted in the text and as reported previously (Maurel et al., 2007)
with the following modifications: for p-Akt and Necl-4 immunofluorescence,
each slide containing teased fibers was submerged in cold acetone for 15 min
at 20°C, washed twice with PBS, and then marked with a liquid blocker
pen (Daido Sangyo). The nerves were blocked for 1 h at RT in 2.5% (wt/vol)
BSA, 1.5% (vol/vol) normal donkey serum, and 0.5% (vol/vol) Triton
X-100 (Sigma-Aldrich). Application of primary and secondary antibodies
and coverslipping was performed as described above. For -DG immunofluorescence, nerve was fixed at RT for 45 min with 4% PFA in PBS. Nerves
were permeabilized in methanol at RT for 5 min and blocked in 1% coldwater fish gelatin (Sigma-Aldrich) in PBS. Primary antibodies were applied
in this blocking solution; secondary antibodies were applied in 5% (wt/vol)
BSA, 1% (vol/vol) normal donkey serum, and 0.4% (vol/vol) Triton X-100
(Sigma-Aldrich).

sodium borohydride in 0.1 M PB for 30 min and then rinsed again in 0.1 M
PB. The cultures were then dislodged from the coverslips with forceps and
transferred to microfuge tubes containing 0.1 M PB. The samples were
spun for 15 min in a microfuge to pellet the cultures and then embedded in
LR White (The London Resin Co., Ltd.). To prepare samples for embedding,
they were dehydrated by two 10-min incubations in 50, 60, 70, and 80%
ethanol. The pellets were then incubated in two 1-h changes of a 1:1 mixture of 80% ethanol and LR White, four 30-min incubations with pure
LR White, and an overnight incubation at 4°C in pure LR White. The next
day the pellets were placed in gelatin capsules filled with fresh LR White
and incubated in a 50°C oven for 2 d to polymerize the resin.
Ultrathin sections (70 nm) were placed on 400-mesh nickel grids.
For post-embedding labeling the grids were subjected to five 2-min washes
in PBSg (PBS containing 0.01 M glycine) and blocked for 10 min in PBSg
containing 1% gelatin. After five 1-min washes in PBSg the grids were
floated, section down, on 20-µl drops of primary antibodies diluted in
PBSg/0.5% BSA or of diluent alone for controls without primary antibody
in a moist chamber at 37°C for 3 h. The grids were then washed six times,
2 min each in PBSg, and incubated on 20-µl drops of 10-nm gold–conjugated
goat anti–rabbit IgG (Electron Microscopy Sciences) in a moist chamber at
RT for 45 min. Unbound secondary antibody was removed by six 2-min
washes in PBSg and four 1-min washes in PBS. The grids were post-fixed in
2% glutaraldehyde/PBS for 15 min. After washing in PBS and then water,
the grids were counterstained with uranyl acetate and lead citrate, washed,
air dried, and analyzed on an electron microscope (model CM10; Philips).
Quantification was performed in a blind fashion by recording the
number of immunogold particles in the adaxon, abaxon, and compact myelin and dividing by the number of total particles. From these values, we subtracted the ratios we obtained for each compartment in the “no primary”
control as a background correction. G-ratios were measured blindly using
the proprietary NIS-Elements AR 3.1 image acquisition software (Nikon).

Immunofluorescence image acquisition
Immunofluorescence images were obtained by laser-scanning confocal microscopy on a microscope (LSM 510; Carl Zeiss) using a 63× oil-immersion
objective (Carl Zeiss) or a wide-field epifluorescence microscope (Eclipse
Ti; Nikon) using 60× and 100× oil immersion objectives at RT. All images
were taken of fixed cultures or sciatic nerve as noted in the text using
Fluoromount-G mounting media (SouthernBiotech).
For confocal microscopy, a series of images taken in the vertical dimension using Z-stacking technology was compressed into a single image
using the 3D projection tool of LSM Image Examiner software (version
4.0.0.421; Carl Zeiss). For wide-field imaging, we used the proprietary
NIS-Elements AR 3.1 image acquisition software (Nikon) without deconvolution. In some cases, the brightness and contrast of immunofluorescence
and immuno-EM images were adjusted in Photoshop CS5 (Adobe Systems); panels in each figure were processed equivalently.

Western blotting
Cultures were lysed with PBS containing 1% SDS, 95 mM NaCl, and 10 mM
EDTA supplemented with protease and phosphatase inhibitors (Roche).
Neonatal sciatic nerve lysates were prepared by flash-freezing with nitrogen, grinding the frozen tissue in the tube with a small pestle in a 75-µl volume, and sonicating briefly. Adult sciatic nerve was also flash-frozen in
nitrogen and macerated in a conventional ceramic mortar and pestle before sonication. All lysates were heated for 3–5 min at 95°C and centrifuged before protein quantification by the BCA method (Thermo Fisher
Scientific). Lysates (10–60 µg) were boiled in sample buffer (50 mM TrisCl, pH 6.8, 5% vol/vol -mercaptoethanol, 2% [wt/vol] sodium dodecyl
sulfate, 0.1% [wt/vol] bromophenol blue, and 10% [vol/vol] glycerol) before loading into a freshly cast polyacrylamide reducing gel and run with
an infrared pre-stained ladder (LI-COR Biosciences). Gels were transferred
to nitrocellulose membrane and blocked (5% nonfat dry milk in Tris-buffered
saline) before primary antibody incubation overnight at 4°C (in 5% BSA in
Tris-buffered saline and Tween 20). After three washing steps in Tris-buffered
saline and Tween 20 (TBST), infrared-compatible secondary antibodies
were applied for 90 min in 5% nonfat dry milk in TBST. After a final three
washing steps in TBST, membranes were imaged and quantified using an
Odyssey machine (LI-COR Biosciences).

Electron microscopy
Mice were perfused with 4% paraformaldehyde and 2.5% glutaraldehyde
in 0.1 M phosphate buffer and 0.1 M d-sucrose at pH 7.4. Sciatic nerves
were dissected and post-fixed in the same solution for 36 h, fixed in a solution of 1% osmium tetroxide in 0.1 M phosphate buffer, and progressively
dehydrated in ethanol and propylene oxide. Finally, nerves were embedded in EMbed 812 (Epon 812 substitute) resin. All reagents used to prepare tissues for electron microscopy were purchased from Electron
Microscopy Sciences.
Embedded nerves were cut into 70-nm ultrathin cross sections using
a UCT microtome (Leica) and glass knife. Sections were placed on grids
and stained with 3% uranyl acetate (aqueous) in 50% methanol and counterstained with Reynold’s lead citrate. Sections were then visualized using
an electron microscope (model CM12; Philips). The g-ratio was calculated
by dividing the diameter of an axon (without the surrounding sheath) by the
diameter of the same axon including the myelin sheath. Over 500 axons
were calculated per mouse and two mice were analyzed per genotype. All
measurements and ultrastructural abnormalities were recorded in a blinded
fashion. G-ratios were calculated using NIS Elements AR imaging software
(version 3.1; Nikon).
The processing of myelinating cultures for immunoelectron microscopy was performed as described previously with slight modifications
(Einheber et al., 1993). Myelinating cultures grown on collagen-coated
glass coverslips for 2 mo were rinsed in PBS containing a phosphatase inhibitor cocktail (Roche) and then fixed in 3.75% acrolein and 2% paraformaldehyde in 0.1 M sodium phosphate buffer, pH 7.4 (0.1 M PB) for
15 min at RT. After washing in 0.1 M PB the cultures were incubated in 0.5%
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Antibodies
Primary rabbit antibodies included: monoclonal and polyclonal Akt phosphosubstrate antibody (1:1,000 for blotting, 1:400 for staining; #9611
and #9614; Cell Signaling Technology); MBP (1:50 for immuno-EM;
#AB980; EMD Millipore); NDRG1 p-Ser330 (1:350 for immunofluorescence and immuno-EM, 1:500 for blotting; #3506; Cell Signaling Technology); NDRG1 p-3xThr (1:350 for co-culture immunofluorescence, 1:2,500
for sciatic nerve immunofluorescence, 1:750 for blotting; #5482; Cell Signaling Technology); total NDRG1 (1:1,000 for co-culture immunofluorescence, 1:3,500 for sciatic nerve immunofluorescence, 1:3,000 for blotting;
a gift of U. Suter, ETH Zurich, Zurich, Switzerland); p-Akt Thr308 and
Ser473 (1:75 for immunofluorescence, 1:500 for blotting; #2965 and
#9271; Cell Signaling Technology); pan-Akt (1:1,250 for blotting; #9272;
Cell Signaling Technology); Redd1 (1:100 blotting; Abcam); PTEN (1:750
blotting; #9559; Cell Signaling Technology); p-S6rp Ser235/6 (1:150
staining, 1:750 blotting, #4856; Cell Signaling Technology); total S6rp
(1:1,200 blotting; #2217; Cell Signaling Technology); and MAG-ECD
(1:100 for immuno-EM) was generated by our laboratory as described
previously (Pedraza et al., 1990). Mouse monoclonal antibodies included:
1-laminin (1:25 for immunofluorescence; clone D18; DSHB, Iowa City, Iowa);
anti–-actin clone AC15 (1:5,000 for blotting; #A-5441; Sigma-Aldrich);

-dystroglycan antibody clone IIH6 (1:400 for staining; a gift of
K. Campbell, University of Iowa, Iowa City, IA; Ervasti and Campbell, 1993);
and Dlg1/Sap97 clone K64/15 (1:250 for blotting; Neuromab, University of California, Davis, Davis, CA). Guinea pig antibodies included:
Caspr1 (1:3,000 for immunofluorescence; a gift of M. Bhat, University of
Texas Health Science Center, San Antonio, TX); Necl-4 generated in our
laboratory and used for staining as described previously (Maurel et al.,
2007); Oct6/POU3F1 (1:16,000 for immunofluorescence; a gift from
J. Dasen, NYU School of Medicine, New York, NY). Other antibodies were
chicken anti-MBP (1:50 for immunofluorescence and 1:750 for blotting;
#AB9348; EMD Millipore), chicken anti-P0 (1:50 for immunofluorescence
and 1:1,000 for blotting; #AB9352; EMD Millipore); sheep anti-Mupp1
(1:100 for immunofluorescence; from O. Peles, Weizmann Institute, Rehovot, Israel).
Secondary antibodies used for immunofluorescence were from Jackson
ImmunoResearch Laboratories, Inc., and raised in donkey and conjugated
to either rhodamine, Alexa Fluor 488, Cy5, Dylight649, or AMCA. Secondary antibodies for Western blotting were from LI-COR Biosciences,
raised in goat, and conjugated to IRDye800 or IRDye680 for dual-color infrared detection.
Schwann cell induction and inhibition
Pure Schwann cells and Schwann cell–neuron co-cultures maintained
in nonmyelinating media for 10–14 d were briefly washed three times in
warmed starvation media (MEM and 10 µM l-glutamine). Cultures were incubated in starvation media for 5–6 h in the presence or absence of 20 µM
LY294002 (LC Labs). Aliquots of 10 µg/ml natural mouse laminin (Life
Technologies) or 1 mg/ml Matrigel (BD) were diluted freshly in the presence or absence of 20 µM LY294002 in the same media. At the end of the
incubation, pre-warmed preparations of diluted natural mouse laminin or
Matrigel were applied to the cultures for 30 min. Cells were then placed
on ice and rinsed with pre-chilled PBS before lysis.
Non-myelinating co-cultures of Schwann cells and sensory neurons
were maintained in serum-containing media for 48 h before an 18-h application of 20 µM LY294004 (LC Labs), 25 nM rapamycin (LC Labs), or
40 µM PF4708671 (Sigma-Aldrich) in defined, serum-free media.
Reverse-transcription PCR
Isolation of mRNA from pure cultures of rat sensory neurons or Schwann
cells was performed with TRIzol reagent (Life Technologies) according
to the manufacturer’s instructions. The mRNA was resuspended in Ambion RNA storage solution (Life Technologies) and quantified using a
spectrophotometer (model DU-800; Beckman Coulter). 1 µg of mRNA
was used to make 20 µl of cDNA using an RNase Easy kit (QIAGEN).
For each PCR reaction performed with the Fermentas DreamTaq master mix (Thermo Fisher Scientific), 1 µl of cDNA was used. The PCR
program for all primers involved 30 cycles of denaturation at 95°C,
annealing at 60°C, and extension at 72°C followed by an additional
final extension step before holding at 4°C. Primers were designed
using the NCBI Blast tool to confirm specificity and standardize product size to 100 bp. The GAPDH primer pair spans an intron–exon
junction. The primer sequences are listed in the 5 to 3 direction as
follows: GAPDH fwd, ACAAGATGGTGAAGGTCGGTGTGA; GAPDH
rev, AGCTTCCCATTCTCAGCCTTGACT; Sgk1 fwd, GCTCCCAGGATGGTTCCGAAGGA; Sgk1 rev, TCCGGAAAGCTTCCGCGTCA; Sgk2 fwd,
AGTCAGGCGAGTGGGTGACAGG; Sgk2 rev, TGGAAACCCCCAGGTTCCAGC; and Sgk3 fwd, TCGCTATTTCTGATACCACCACAACC;
Sgk3 rev, AGGCTCACTCCTGGTCTCAAGTTCA.
Mouse models
All of the mouse models used in this project have been described previously. The 2-laminin knockout was generated by knocking a pMC1neo
polyA+ cassette (Agilent Technologies) into an exon (aa 128–209) as
described previously (Nakagawa et al., 2001). The 1 integrin conditional allele was generated by targeting two loxP sites to both sides of the
first coding exon of the gene (Graus-Porta et al., 2001; Feltri et al.,
2002). The 4 integrin conditional allele (Nodari et al., 2008) was generated using the m4intc targeting vector, which contains the first 7 introns and exons of 4 genomic DNA and the necessary loxP sites
(Dowling et al., 1996). The dystroglycan conditional allele was generated by inserting a floxed NEO cassette into the exon 2 locus (Moore
et al., 2002). The P0-CRE line was generated by cloning in recombinant
CRE downstream of the full-length 6-kb promoter of the mouse P0 gene
(Feltri et al., 1999). Two Sgk1-null lines in the same C57/Sv129 mixed
background were used in this study. The first was generated by cloning a

loxP site into intron 1 and two others in intron 6 flanking a NEO cassette
(which was flanked by FRT sites) and mated with the global Cre-deleter
line BALB/c-Tg(CMV-cre)1Gcn/J from The Jackson Laboratory (Fejes-Tóth
et al., 2008). The other Sgk1-null line was generated using a similar approach in which a loxP site was introduced into intron 3 and two others
flanking a NEO casette in intron 11; the resulting homologously recombined ES cell clones were then transiently transfected with Cre recombinase (Wulff et al., 2002). The Sgk3-null animal was generated by replacing
parts of exons 10 and 11 as well as the intron between them with an inframe STOP codon (McCormick et al., 2004). The 4 integrin–signaling
mutant was generated by replacing the signaling moiety of the cytoplasmic domain of 4 C-terminal to Thr1355 with a stop codon, a SV40
polyadenylation signal, and a NEO cassette (Nikolopoulos et al., 2004).
The stretcher mouse is a spontaneous deletion of exons 10–14 of the
Ndrg1 gene (King et al., 2011). The Neuregulin1 type III CRD-null mouse
was generated by homologous recombination of a nonsense mutation
and an antisense NEO cassette into the cysteine-rich domain region of
the Neuregulin1 gene (Wolpowitz et al., 2000). All three Akt isoformspecific mice were obtained from The Jackson Laboratory.
Statistical methods
All one-way ANOVA and two-tailed Student’s t tests performed were computed using Excel 2007 (Microsoft) or Prism (GraphPad Software).
Online supplemental material
Fig. S1 demonstrates the subcellular localization of NDRG1 and phosphosubstrates. Fig. S1 A shows that total and phospho-specific NDRG1 antibodies stained wild type but not stretcher co-cultures, indicating they are
specific. Fig. S1 B shows that staining of stretcher cultures with the
p-Sub–staining antibody was reduced, notably in the abaxon, but was not
abolished. Fig. S1 C demonstrates that p-Akt localizes to the paranodes,
identified by expression of Caspr, as myelin sheaths mature; p-Akt is similarly localized to the paranodes of neonatal sciatic nerves. Fig. S2 A
shows ultrastructural localization of p-NDRG1, myelin-associated glycoprotein, and MBP by immunoelectron microscopy of myelinating co-cultures,
quantified in Fig. S2 B; these results support an abaxonal localization
of p-NDRG1 (S330). Fig. S2 C demonstrates that S6rp phosphorylation
is dependent on Neuregulin1 type III expression in the co-cultures. Fig. S3
shows that adding Matrigel to pure Schwann cell cultures does not increase phosphorylation of NDRG1 (A), whereas adding Matrigel or
laminin up-regulates phosphorylation of NDRG1 when Schwann cells
are co-cultured with neurons (B), suggesting the laminin receptor is expressed in an axon-dependent manner; phosphorylation is blocked by
the LY inhibitor. Fig. S3 C shows that soluble Neuregulin1 type III also
increases NDRG1 phosphorylation in nonmyelinating cultures, which
lack distinct cytoplasmic compartments. Fig. S4 A demonstrates how
laminin receptors, particularly 4 integrin, are necessary for phosphorylation of NDRG1 but not S6rp. Fig. S4, C and D show that kinases that
phosphorylated NDRG1 include Akt1 and Sgk1 at P10 and Sgk1 and
Sgk3 in the adult nerve. Fig. S5 A demonstrates that loss of 4 integrin
signaling causes modest hypermyelination. Fig. S5 B shows that hypermyelination in the Sgk1 nulls is unlikely to be the result of known negative regulators of myelination such as DLG1 and REDD1; thus, whereas
REDD1 levels were modestly reduced, mTOR activity (indicated by p-S6rp
levels), its negatively regulated effector, was not consistently increased.
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.201307057/DC1.
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